A Consideration of the Potential Taxation of Cannabis in South Africa

Total Page:16

File Type:pdf, Size:1020Kb

A Consideration of the Potential Taxation of Cannabis in South Africa A Consideration of the Potential Taxation of Cannabis in South Africa C D TAYLOR orcid.org/0000-0001-6561-2006 A mini-dissertation submitted in partial fulfilment of the requirements for the degree Magister Commercii in South African and International Taxation at the Potchefstroom Campus of the North-West University Supervisor: Prof Karina Coetzee Graduation: December 2020 Student number: 31370772 DECLARATION I declare that the mini-dissertation titled ‘A consideration of the potential taxation of cannabis in South Africa’ is my own work, that all sources used or quoted have been indicated and acknowledged by means of complete references and that it has not been previously submitted by me, or another person for degree purposes at this, or another, university. I know that plagiarism is wrong. It is the use of another’s work that is presented to be my own work. I have not allowed, and will not allow, anyone to copy this mini-dissertation with the intention of claiming it as his own work. i ACKNOWLEDGEMENTS I am grateful and appreciative of the following persons: Firstly, thank you to our Heavenly Father, who gave me the intellect, strength, health and willingness to pursue my goals further, Philippians 4:12 ‘I can do all things through Him who strengthens and empowers me.’ I would like to express my sincere gratitude to my dissertation supervisor Professor Karina Coetzee, who allowed me to choose my research topic and explore a field of research that was completely new to me. She remained calm and was always willing to assist in times of difficulty. My sincere thanks also to Lizelle Snyman of North-West University’s library, who provided valuable guidance on potential sources of literature and Elsa Esterhuizen who took care of the referencing of some of the more obscure literature that were sourced. Last, but by no means least, I would like to thank my husband, George Taylor, for his belief in me, moral support, understanding and always motivating me to higher standards. ii ABSTRACT Taxation is part of the daily lives of most persons in the world. A new product supplied into a market is likely to be subject to some form of taxation. Taxation of a new product for example cannabis requires rigorous planning due to its diversity and complexity. South Africa has a long way to go considering the possible legalisation of cannabis and the resulting tax legislation of it. The most recent changes made were the finalisation of the Cannabis for Private Purposes Bill of 2020. According to a Government statement released on 06 August 2020, the submission to Parliament was approved by the Minister of Justice and Correctional Services and noted in the Government Gazette no 43595, vol. 662 on 07 August 2020. The mini-dissertation does not include this latest legislation, due to not being approved by Parliament yet. Certain countries including various American states have not yet approved cannabis legislation. They have, however, legalised the recreational and medicinal use of it. Many other countries are exploring the possibilities should the use of cannabis no longer be prohibited. Due to a lack of appropriate data and studies in South Africa, international studies and legislation could be used to supplement this shortage of information to formulate tax policies for cannabis in South Africa. This report confirms that by legalising the recreational and medicinal use of cannabis, a government may reap enormous financial benefits, bearing in mind its versatility. Careful consideration is needed in establishing the best tax policy, to avoid subjecting cannabis to over tax. New taxes are not required but rather that existing tax legislation should be enforced. iii GLOSSARY OF TERMS Term Definition Cannabis Cannabis sativa, also known as hemp, is a species of the Cannabaceae family of plants. Cannabinoid Characterised by chronic cannabis use, cyclic episodes of nausea Hyperemesis Syndrome and vomiting, and frequent hot bathing. Criminalised Turned into a criminal offence by making it illegal. Dagga A common South African term for cannabis, also known as weed or marijuana (marihuana). Decriminalised Cease to treat (something) as illegal or as a criminal offence Hemp Sativa L, is an industrial crop cultivated all over the world Legalisation This is the process of changing the legal status of an activity to be permissible by law. It may still be regulated by law enforcement or other regulatory bodies. Schizophrenia Mental (complex brain) disorder. Sin taxes Excise duty and a levy imposed on high-volume daily-consumable products. iv TABLE OF CONTENTS DECLARATION ......................................................................................................................... I ACKNOWLEDGEMENTS ......................................................................................................... II ABSTRACT ............................................................................................................................. III GLOSSARY OF TERMS .......................................................................................................... IV CHAPTER 1: INTRODUCTION ................................................................................................ 1 1.1 Background ...................................................................................................... 1 1.1.1 The history of cannabis ....................................................................................... 1 1.1.2 Versatility of cannabis ......................................................................................... 2 1.1.3 Progress in legalising cannabis in South Africa................................................... 3 1.1.4 Medicinal application .......................................................................................... 5 1.1.5 Taxes (including excise duties, levies and value-added tax) ............................... 6 1.2 Motivation of topic ............................................................................................ 7 1.3 Problem statement ........................................................................................... 8 1.4 Research objectives ......................................................................................... 9 1.4.1 Main objective..................................................................................................... 9 1.4.2 Secondary objectives .......................................................................................... 9 1.5 Research design and methodology ................................................................ 9 1.5.1 Research design ................................................................................................. 9 1.5.2 Research methodology ..................................................................................... 10 1.5.3 Conclusion ........................................................................................................ 12 1.6 Overview of the chapters ............................................................................... 13 v CHAPTER 2: EXPLORING MULTIPLE USES OF CANNABIS ............................................. 14 2.1 Introduction .................................................................................................... 14 2.2 Medicinal use of cannabis ............................................................................. 15 2.2.1 Treatment of different conditions ...................................................................... 18 2.2.1.1 Alzheimer’s disease .......................................................................................... 18 2.2.1.2 Seizure disorders .............................................................................................. 18 2.2.1.3 Cancer cell killing at the animal testing stage ................................................... 18 2.2.1.4 Other conditions ............................................................................................... 18 2.2.1.5 Synthetic prescription cannabinoid products ..................................................... 20 2.2.2 Method to obtain medical cannabis in America ................................................. 20 2.3 Recreational use of cannabis ........................................................................ 20 2.3.1 Different ways to use cannabis ......................................................................... 21 2.3.2 Short-term side effects ...................................................................................... 22 2.3.3 Long-term side effects ...................................................................................... 22 2.3.4 Other health effects .......................................................................................... 23 2.3.4.1 Physical effects ................................................................................................. 23 2.3.4.2 Mental effects ................................................................................................... 24 2.3.4.3 Other points to remember ................................................................................. 24 2.4 Industrial use of cannabis (Hemp) ................................................................ 24 2.4.1 Hemp history .................................................................................................... 26 2.4.2 Hemp uses ....................................................................................................... 27 2.5 Cannabis and religion ...................................................................................
Recommended publications
  • Experiences of Disengagement from Mental Health Services: an Interpretative Study
    EXPERIENCES OF DISENGAGEMENT FROM MENTAL HEALTH SERVICES: AN INTERPRETATIVE STUDY by CHRISTOPHER WAGSTAFF A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY Nursing, Health & Population Sciences College of Medical & Dental Sciences University of Birmingham 2015 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Whilst there is evidence of a range of effective treatments available for people with severe mental health problems (SMHP), people frequently disengage from mental health services (MHS). This thesis investigates experiences of disengagement of people with SMHP and comprises two studies: 1) semi-structured interviews to elicit the experiences of people with SMHP and a history of disengagement from MHS; and 2) building on those findings, focus groups with staff from assertive outreach teams (specialising in providing care for people with SMHP and a history of disengagement). The participants were those perceived as the most disengaged from MHS yet they were willing to engage with the research. Interpretative phenomenological analysis was used to develop themes for individual participants and then across the participants. Disengagement from MHS was part of a wider experience of a limited connection to social structures, including an ambivalent and complex relationship with MHS.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Hallucinogens - LSD, Peyote, Psilocybin, and PCP Hallucinogenic compounds found in some • Psilocybin (4-phosphoryloxy-N,N- plants and mushrooms (or their extracts) dimethyltryptamine) is obtained from have been used—mostly during religious certain types of mushrooms that are rituals—for centuries. Almost all indigenous to tropical and subtropical hallucinogens contain nitrogen and are regions of South America, Mexico, and classified as alkaloids. Many hallucinogens the United States. These mushrooms have chemical structures similar to those of typically contain less than 0.5 percent natural neurotransmitters (e.g., psilocybin plus trace amounts of acetylcholine-, serotonin-, or catecholamine- psilocin, another hallucinogenic like). While the exact mechanisms by which substance. hallucinogens exert their effects remain • PCP (phencyclidine) was developed in unclear, research suggests that these drugs the 1950s as an intravenous anesthetic. work, at least partially, by temporarily Its use has since been discontinued due interfering with neurotransmitter action or to serious adverse effects. by binding to their receptor sites. This DrugFacts will discuss four common types of How Are Hallucinogens Abused? hallucinogens: The very same characteristics that led to • LSD (d-lysergic acid diethylamide) is the incorporation of hallucinogens into one of the most potent mood-changing ritualistic or spiritual traditions have also chemicals. It was discovered in 1938 led to their propagation as drugs of abuse. and is manufactured from lysergic acid, Importantly, and unlike most other drugs, which is found in ergot, a fungus that the effects of hallucinogens are highly grows on rye and other grains. variable and unreliable, producing different • Peyote is a small, spineless cactus in effects in different people at different times.
    [Show full text]
  • Cannabis Rescheduling: a Global Introduction by Dania Putri
    Briefing paper October 2020 Cannabis rescheduling: A global introduction By Dania Putri Executive Summary Background: Cannabis and the UN Following its first-ever critical review of cannabis, in Jan- drug scheduling system uary 2019 the World Health Organization issued a collec- Around the world, most national legislations relating to tion of formal recommendations to reschedule cannabis the consumption, production, and distribution of can- and cannabis-related substances. 53 member states of nabis and cannabis-related substances are rooted in the the Commission on Narcotic Drugs (CND) are set to vote current global drug control system as institutionalised on these recommendations in December 2020. by the three main UN drug conventions.1 Over 300 sub- stances listed under these conventions are subject to Among the WHO’s recommendations, two in particular varying degrees of control depending on the categories appear to be the most urgent: namely recommendation in which they have been scheduled, ‘defined according 5.1 (concerning the acknowledgment of cannabis’ me- to the dependence potential, abuse liability and thera- dicinal usefulness) and recommendation 5.4 (concerning peutic usefulness of the drugs included in them’.2 It is the need to remove the term ‘extracts and tinctures of thus crucial to note that these UN drug conventions ex- cannabis’ from the 1961 Convention). Supporting these ist to ensure the global (legal) trade in, production, and two recommendations presents an opportunity for gov- use of controlled substances for medical and scientific ernments and civil society to further reform and decol- purposes, while aiming to prevent diversion to the il- onise drug control approaches across the globe, as well legal market which typically caters to non-medical and as to strengthen the international legal basis for existing non-scientific or recreational needs.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • WHO Expert Committee on Drug Dependence Pre-Review ……………
    WHO Expert Committee on Drug Dependence Pre-Review …………….. Cannabis plant and cannabis resin Section 5: Epidemiology This report contains the views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization 1 © World Health Organization 2018 All rights reserved. This is an advance copy distributed to the participants of the 40th Expert Committee on Drug Dependence, before it has been formally published by the World Health Organization. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.
    [Show full text]
  • From Sacred Plants to Psychotherapy
    From Sacred Plants to Psychotherapy: The History and Re-Emergence of Psychedelics in Medicine By Dr. Ben Sessa ‘The rejection of any source of evidence is always treason to that ultimate rationalism which urges forward science and philosophy alike’ - Alfred North Whitehead Introduction: What exactly is it that fascinates people about the psychedelic drugs? And how can we best define them? 1. Most psychiatrists will define psychedelics as those drugs that cause an acute confusional state. They bring about profound alterations in consciousness and may induce perceptual distortions as part of an organic psychosis. 2. Another definition for these substances may come from the cross-cultural dimension. In this context psychedelic drugs may be recognised as ceremonial religious tools, used by some non-Western cultures in order to communicate with the spiritual world. 3. For many lay people the psychedelic drugs are little more than illegal and dangerous drugs of abuse – addictive compounds, not to be distinguished from cocaine and heroin, which are only understood to be destructive - the cause of an individual, if not society’s, destruction. 4. But two final definitions for psychedelic drugs – and those that I would like the reader to have considered by the end of this article – is that the class of drugs defined as psychedelic, can be: a) Useful and safe medical treatments. Tools that as adjuncts to psychotherapy can be used to alleviate the symptoms and course of many mental illnesses, and 1 b) Vital research tools with which to better our understanding of the brain and the nature of consciousness. Classifying psychedelic drugs: 1,2 The drugs that are often described as the ‘classical’ psychedelics include LSD-25 (Lysergic Diethylamide), Mescaline (3,4,5- trimethoxyphenylathylamine), Psilocybin (4-hydroxy-N,N-dimethyltryptamine) and DMT (dimethyltryptamine).
    [Show full text]
  • Headshop Highs & Lows
    HeadshopHeadshop HighsHighs && LowsLows AA PresentationPresentation byby DrDr DesDes CorriganCorrigan HeadshopsHeadshops A.K.A.A.K.A. ““SmartSmart ShopsShops””,, ““HempHemp ShopsShops””,, ““HemporiaHemporia”” oror ““GrowshopsGrowshops”” RetailRetail oror OnlineOnline OutletsOutlets sellingselling PsychoactivePsychoactive Plants,Plants, ‘‘LegalLegal’’ && ““HerbalHerbal”” HighsHighs asas wellwell asas DrugDrug ParaphernaliaParaphernalia includingincluding CannabisCannabis growinggrowing equipment.equipment. Headshops supply Cannabis Paraphernalia HeadshopsHeadshops && SkunkSkunk--typetype (( HighHigh Strength)Strength) CannabisCannabis 1.1. SaleSale ofof SkunkSkunk--typetype seedsseeds 2.2. AdviceAdvice onon SinsemillaSinsemilla TechniqueTechnique 3.3. SaleSale ofof HydroponicsHydroponics && IntenseIntense LightingLighting .. CannabisCannabis PotencyPotency expressedexpressed asas %% THCTHC ContentContent ¾¾ IrelandIreland ¾¾ HerbHerb 6%6% HashHash 4%4% ¾¾ UKUK ¾¾ HerbHerb** 1212--18%18% HashHash 3.4%3.4% ¾¾ NetherlandsNetherlands ¾¾ HerbHerb** 20%20% HashHash 37%37% * Skunk-type SkunkSkunk--TypeType CannabisCannabis && PsychosisPsychosis ¾¾ComparedCompared toto HashHash smokingsmoking controlscontrols ¾¾ SkunkSkunk useuse -- 77 xx riskrisk ¾¾ DailyDaily SkunkSkunk useuse -- 1212 xx riskrisk ¾¾ DiDi FortiForti etet alal .. Br.Br. J.J. PsychiatryPsychiatry 20092009 CannabinoidsCannabinoids ¾¾ PhytoCannabinoidsPhytoCannabinoids-- onlyonly inin CannabisCannabis plantsplants ¾¾ EndocannabinoidsEndocannabinoids –– naturallynaturally occurringoccurring
    [Show full text]
  • Soma and Haoma: Ayahuasca Analogues from the Late Bronze Age
    ORIGINAL ARTICLE Journal of Psychedelic Studies 3(2), pp. 104–116 (2019) DOI: 10.1556/2054.2019.013 First published online July 25, 2019 Soma and Haoma: Ayahuasca analogues from the Late Bronze Age MATTHEW CLARK* School of Oriental and African Studies (SOAS), Department of Languages, Cultures and Linguistics, University of London, London, UK (Received: October 19, 2018; accepted: March 14, 2019) In this article, the origins of the cult of the ritual drink known as soma/haoma are explored. Various shortcomings of the main botanical candidates that have so far been proposed for this so-called “nectar of immortality” are assessed. Attention is brought to a variety of plants identified as soma/haoma in ancient Asian literature. Some of these plants are included in complex formulas and are sources of dimethyl tryptamine, monoamine oxidase inhibitors, and other psychedelic substances. It is suggested that through trial and error the same kinds of formulas that are used to make ayahuasca in South America were developed in antiquity in Central Asia and that the knowledge of the psychoactive properties of certain plants spreads through migrants from Central Asia to Persia and India. This article summarizes the main arguments for the botanical identity of soma/haoma, which is presented in my book, The Tawny One: Soma, Haoma and Ayahuasca (Muswell Hill Press, London/New York). However, in this article, all the topics dealt with in that publication, such as the possible ingredients of the potion used in Greek mystery rites, an extensive discussion of cannabis, or criteria that we might use to demarcate non-ordinary states of consciousness, have not been elaborated.
    [Show full text]
  • Problematic Use of Nitrous Oxide by Young Moroccan–Dutch Adults
    International Journal of Environmental Research and Public Health Article Problematic Use of Nitrous Oxide by Young Moroccan–Dutch Adults Ton Nabben 1, Jelmer Weijs 2 and Jan van Amsterdam 3,* 1 Urban Governance & Social Innovation, Amsterdam University of Applied Sciences, P.O. Box 2171, 1000 CD Amsterdam, The Netherlands; [email protected] 2 Jellinek, Department High Care Detox, Vlaardingenlaan 5, 1059 GL Amsterdam, The Netherlands; [email protected] 3 Amsterdam University Medical Center, Department of Psychiatry, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands * Correspondence: [email protected] Abstract: The recreational use of nitrous oxide (N2O; laughing gas) has largely expanded in recent years. Although incidental use of nitrous oxide hardly causes any health damage, problematic or heavy use of nitrous oxide can lead to serious adverse effects. Amsterdam care centres noticed that Moroccan–Dutch young adults reported neurological symptoms, including severe paralysis, as a result of problematic nitrous oxide use. In this qualitative exploratory study, thirteen young adult Moroccan–Dutch excessive nitrous oxide users were interviewed. The determinants of problematic nitrous oxide use in this ethnic group are discussed, including their low treatment demand with respect to nitrous oxide abuse related medical–psychological problems. Motives for using nitrous oxide are to relieve boredom, to seek out relaxation with friends and to suppress psychosocial stress and negative thoughts. Other motives are depression, discrimination and conflict with friends Citation: Nabben, T.; Weijs, J.; van or parents. The taboo culture surrounding substance use—mistrust, shame and macho culture— Amsterdam, J. Problematic Use of frustrates timely medical/psychological treatment of Moroccan–Dutch problematic nitrous oxide Nitrous Oxide by Young users.
    [Show full text]
  • Religious Use of Drugs
    Religious Use of Drugs Jay Leiderman Leiderman Devine LLP 5700 Ralston St #211 Ventura CA 93003 805 654 0200 www.leidermandevine.com [email protected] NORML PRESENTATION, Aspen, CO, 5 June 2011 IN THE BEGINNING . • And God said, Let the earth bring forth grass, and the herb yielding seed... -Genesis 1:11 I. FEDERAL LAW • “Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof . .” • It is the “free exercise clause” that is implicated by laws of general applicability that prohibit the religious use of drugs. I. FEDERAL LAW • The federal statute on religious use of drugs is the Religious Freedom Restoration Act (‘RFRA’). (42 U.S.C. § 2000bb et seq.) • RFRA provides that government, “shall not substantially burden a person’s exercise of religion even if the burden results from a rule of general applicability,” unless it passes the strict scrutiny test. I. FEDERAL LAW • The “RFRA is unconstitutional and does not trump California statutes prohibiting the sale or possession of marijuana for sale. ‘When the exercise of religion has been burdened in an incidental way by a law of general application, it does not follow that the persons affected have been burdened any more than other citizens, let alone burdened because of their religious beliefs.’ (City of Boerene v. Flores, (1997), 521 U.S. at p. 535 [138 L.Ed.2d at p. 648].)” I. FEDERAL LAW • The test applied to Federal Statutes and Federal Territories is the RFRA Test • The States revert to Employment Division v. Smith (1990) 494 U.S.
    [Show full text]
  • Once Off Paint Dealsexclusive To
    THE RISING SUN Lenasia - November 29 - December 5, 2016 Page 1 - SHOE REPAIRS - KEYS CUT - DRY CLEANING - TAILORING Your No.1 Community newspaper Distributed DOOR 2 DOOR in Lenasia, Lenasia South, Zakariyya Park, Azaadville, Roshnee, Free Copies Dadaville, De Deur businesses, Migson Manor, Bushkoppies, Nancefield and Part of Ennerdale 33,000 Weekly Find us on www.risingsunlenasia.co.za @risingsunlens 071 613 7485 Rising Sun Lenasia E-mail: [email protected] VOL.9 NO. 44 November 29 - December 5, 2016 Tel: (011) 852 0842/3 Fax: (011) 852 0291 Cash for silence following Illegal connections ‘daughter-in-laws’ alleged rape claim three lives Page 3 BY LERATO PHOSISI electricity (connections). I hope this serves says Eskom. Zarina as a lesson to other informal settlements,” “We have identified that the biggest con- HE past few weeks has seen a series Mulaudzi said. tributors to electrical accidents, injuries, Motala of electrocutions in the Lenasia area City Power has said more than 80 percent and fatalities are contact with low-hanging Twith the smallest victim being only of recent power outages nationally were as conductors, unsafe connections, vandal- elected two years old. the result of illegal connections overloading ism, illegal power connections and cable The toddler was electrocuted in a passage the network. theft. Safety is a major concern and we urge at the Precast informal settlement on No- Electricity is currently being installed in customers: Joburg vember 23. the area to curb the scourge of illegal elec- · not to bypass circuit breakers in houses In another incident a 45-year-old man who tricity connections.
    [Show full text]
  • South African Central Drug Authority Position Paper On
    SOUTH AFRICAN CENTRAL DRUG AUTHORITY POSITION PAPER ON CANNABIS December 2004 NOT TO BE DISTRIBUTED OUTSIDE THE CENTRAL DRUG AUTHORITY ACKNOWLEDGEMENTS The contributions of all those who facilitated the completion of this document are gratefully acknowledged: • The Department of Social Development for financial support and printing; • Ms Evodia Mokoko of the Central Drug Authority Secretariat for facilitating and coordinating the overall process; • The Central Drug Authority Research Sub-Committee, and in particular Prof. Dorothy Malaka (Chairperson of the Research Sub-Committee and Deputy Chairperson of the Central Drug Authority), Dr Lee da Rocha Silva, and Mr Christo Mynhardt who compiled this paper; • The Legal Department of the Department of Social Development and Central Drug Authority members for reviewing earlier drafts of this paper, and in particular Mr David Bayever, Mr Grant Jardine, Dr Charles Parry, Prof. Solly Rataemane and Ms Bes Steyn; • Senior students in the Department of Social Work at the University of Limpopo for assisting in the accumulation and summary of relevant literature; • Ms Ina Stahmer for copy-editing and Ms Annemarie Booyens for technical assistance. iii EXECUTIVE SUMMARY This paper aims to provide a rational and coherent framework for discussion and policy development in South Africa regarding cannabis use and trade, apart from serving as an information document. The conclusions reached on the subject are based on a review of available literature on the nature, extent, effects or consequences of cannabis use as well as related government policies in South Africa and to some extent in other countries. The paper notes that cannabis—or more specifically Cannabis Sativa—grows in many parts of the world, including South Africa.
    [Show full text]